Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series

Lai, C. Benjamin; Smith, Tyler; Lee, Agnes Yuet Ying

doi:10.1007/s11239-020-02320-3

Cited by 3 publications

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although no complications in the form of HIT have been observed during the use of EX in the paediatric population, the platelet count should be monitored before starting treatment and every 48-96 hours during treatment in patients in stable clinical conditio, or immediately in the case of deterioration of the patient's condition, clinical symptoms of thrombocytopenia or, paradoxically, new TEI [102][103][104]. Classically, HIT occurs between 2 -21 days after initiation of treatment, and the risk of its occurrence is greater after surgery, especially cardiac surgery, as well as in cancer patients [105][106][107]. If HIT is strongly suspected, EX administration should be stopped immediately, ultrasound diagnostics should be performed to exclude the presence of a thrombus, and anti-heparin antibodies and, possibly, functional tests should be determined [107][108][109].…”

Section: Monitoring Of Laboratory Tests During Enoxaparin Treatmentmentioning

confidence: 99%

Thromboembolic complications in newborns – diagnostic value of D-dimers concentration and proposed outline of enoxaparin use

Wątroba¹,

Bryda²

2022

J Pre Clin Clin Res.

View full text Add to dashboard Cite

Introduction and Objective. Among paediatric patients, thromboembolic complications (TECs) are most often observed in newborns, especially premature infants requiring intensive care and the use of central vascular accesses. Prognosis depends on the presence of comorbidities, maturity of the newborn, and the location and size of the thrombus. The basic laboratory test that allows for the exclusion of TECs is assessment of the plasma D-dimers concentration, the correct value of which sufficiently excludes the presence of TECs. Review methods. The review attempts to systematize existing knowledge on the plasma D-dimers concentration in newborns, and creates a scheme for using enoxaparin (EX), helpful in everyday clinical practice. Brief description of the state of knowledge. There are single studies devoted to assessing the plasma D-dimers concentration in newborns, but they agree that the concentration in normal healthy adults does not apply to newborns, regardless of the postmenstrual age (PMA), because the plasma D-dimers concentration found in newborns are significantly higher, despite the lack of clinical and ultrasound features of thrombosis and normal results of other parameters of the coagulation system. Increased plasma D-dimers concentration in newborns may be due to delayed renal clearance of D-dimers and to physiological mechanisms related to the closing of the venous duct (DV) and arterial duct (DA) in the newborn. Summary. Plasma D-dimers concentration is one of the basic laboratory markers of TECs, and is a starting point for further diagnostics and a valuable guide when making decisions about prophylactic and therapeutic procedures. The use of EX, as well as other LMWHs, is slowly becoming the treatment of choice in paediatric patients and is increasingly more often recommended in newborns.

show abstract

Section: Monitoring Of Laboratory Tests During Enoxaparin Treatmentmentioning

confidence: 99%

Thromboembolic complications in newborns – diagnostic value of D-dimers concentration and proposed outline of enoxaparin use

Wątroba¹,

Bryda²

2022

J Pre Clin Clin Res.

View full text Add to dashboard Cite

show abstract

Heparin/low-molecular-weight-heparins

2023

Reactions Weekly

View full text Add to dashboard Cite

Double Emergency: A Case of Concurrent Heparin-Induced Thrombocytopenia and Acute Promyelocytic Leukemia

Schuldt,

Samour

2024

Cureus

View full text Add to dashboard Cite

Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series

Cited by 3 publications

References 26 publications

Thromboembolic complications in newborns – diagnostic value of D-dimers concentration and proposed outline of enoxaparin use

Thromboembolic complications in newborns – diagnostic value of D-dimers concentration and proposed outline of enoxaparin use

Heparin/low-molecular-weight-heparins

Double Emergency: A Case of Concurrent Heparin-Induced Thrombocytopenia and Acute Promyelocytic Leukemia

Contact Info

Product

Resources

About